Weightloss Tablets

We offer two scientifically-proven weight management solutions in the form of tablets - Rybelsus and Mysimba. These options have undergone rigorous clinical studies to ensure their safety and effectiveness, and they have successfully assisted countless individuals in achieving their weight loss objectives.

Rybelsus is an oral medication that falls under the category of glucagon-like peptide-1 (GLP-1) receptor agonists, designed to aid in weight loss. On the other hand, Mysimba is a combination of two oral medications, bupropion and naltrexone, intended for weight loss and management. Although both medications effectively regulate appetite and cravings, they operate through distinct mechanisms of action.

Rybelsus (Semaglutide) Tablets

Rybelsus (Semaglutide)

Rybelsus (Semaglutide)

Rybelsus is an oral tablet taken once daily, specifically designed to regulate appetite and cravings by slowing down stomach emptying and influencing the brain's appetite control center. Clinically proven to be effective in weight loss, Rybelsus is also utilized for the treatment of type 2 diabetes.

How to take: Daily oral tablets
Starting Dosage: 3mg daily
Price: 1 month: £175 / 3 months: £480
Order Now

Who are Eligible?

Our team of medical professionals will collaborate with you to identify the most suitable treatment option tailored to your specific needs and objectives.

Eligibility Criteria:

  • BMI ≥ 30 kg/m2
  • BMI ≥ 27 kg/m2 with weight-related comorbidities.

Who are not Eligible?

  • Patients under 18 years of age
  • Pregnant or breastfeeding women
  • Patients diagnosed with eating disorders
  • Those with active diabetic gastroparesis
  • Those with active inflammatory bowel disease
  • Individuals with decompensated congestive heart failure
  • Severe renal impairment (Kidney failure)
  • Severe hepatic impairment (Liver failure)
  • Individuals with a family history of medullary thyroid carcinoma.